136 related articles for article (PubMed ID: 7706385)
1. Drug efflux mediated by the human multidrug resistance P-glycoprotein is inhibited by cell swelling.
Sardini A; Mintenig GM; Valverde MA; Sepúlveda FV; Gill DR; Hyde SC; Higgins CF; McNaughton PA
J Cell Sci; 1994 Dec; 107 ( Pt 12)():3281-90. PubMed ID: 7706385
[TBL] [Abstract][Full Text] [Related]
2. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells.
Ehring GR; Osipchuk YV; Cahalan MD
J Gen Physiol; 1994 Dec; 104(6):1129-61. PubMed ID: 7699367
[TBL] [Abstract][Full Text] [Related]
3. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
4. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
Molinari A; Calcabrini A; Meschini S; Stringaro A; Del Bufalo D; Cianfriglia M; Arancia G
Int J Cancer; 1998 Mar; 75(6):885-93. PubMed ID: 9506534
[TBL] [Abstract][Full Text] [Related]
5. P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope.
Hämmerle SP; Rothen-Rutishauser B; Krämer SD; Günthert M; Wunderli-Allenspach H
Eur J Pharm Sci; 2000 Nov; 12(1):69-77. PubMed ID: 11121735
[TBL] [Abstract][Full Text] [Related]
6. Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein.
Sajid A; Lusvarghi S; Murakami M; Chufan EE; Abel B; Gottesman MM; Durell SR; Ambudkar SV
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29609-29617. PubMed ID: 33168729
[TBL] [Abstract][Full Text] [Related]
7. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
Hu Z; Zhou Z; Hu Y; Wu J; Li Y; Huang W
PLoS One; 2015; 10(2):e0116886. PubMed ID: 25689592
[TBL] [Abstract][Full Text] [Related]
8. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
9. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels.
Hardy SP; Goodfellow HR; Valverde MA; Gill DR; Sepúlveda V; Higgins CF
EMBO J; 1995 Jan; 14(1):68-75. PubMed ID: 7828597
[TBL] [Abstract][Full Text] [Related]
11. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
12. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport.
Liao ZG; Tang T; Guan XJ; Dong W; Zhang J; Zhao GW; Yang M; Liang XL
Molecules; 2016 Nov; 21(12):. PubMed ID: 27886150
[TBL] [Abstract][Full Text] [Related]
13. Effects of the chemosensitizer verapamil on P-glycoprotein substrate efflux in rainbow trout hepatocytes.
Johnston CU; Kennedy CJ
Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jan; 275():109763. PubMed ID: 37820937
[TBL] [Abstract][Full Text] [Related]
14.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
15. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
16. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
18. Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype.
Beumer JH; Buckle T; Ouwehand M; Franke NE; Lopez-Lazaro L; Schellens JH; Beijnen JH; van Tellingen O
Invest New Drugs; 2007 Feb; 25(1):1-7. PubMed ID: 16633714
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
20. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
Dahan A; Sabit H; Amidon GL
AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
